DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.484-485, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Basıldığı Ülke: ELECTR NETWORK
- Sayfa Sayıları: ss.484-485
- Gazi Üniversitesi Adresli: Evet